Lymphomas of the Head and Neck

Extranodal Lymphomas

Volumn , Issue , 2011, Pages 34-80

  Ferry, Judith A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867477710     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4579-3.10003-8     Document Type: Chapter

References (195)

1. Bairey O., Kremer I., Rakowsky E., et al. Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma. Cancer 1994, 73:2395-2399.
2. Freeman C., Berg J., Cutler S. Occurrence and prognosis of extranodal lymphomas. Cancer 1972, 29:252-260.
3. Ferry J., Fung C., Zukerberg L., et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 2007, 31:170-184.
4. Auw-Haedrich C., Coupland S., Kapp A., et al. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Br J Ophthalmol 2001, 85:63-69.
5. Baldini L., Blini M., Guffanti A., et al. Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol 1998, 9:779-781.
6. White W.L., Ferry J.A., Harris N.L., Grove A.S. Ocular adnexal lymphoma: a clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue (MALT) type. Ophthalmology 1995, 102:1994-2006.
7. Coupland S., Krause L., Delecluse H.-J., et al. Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology 1998, 105:1430-1441.
8. Wotherspoon A., Diss T., Pan L., et al. Primary low-grade B-cell lymphoma of the conjunctiva: a mucosa-associated lymphoid tissue type lymphoma. Histopathology 1993, 23:417-424.
9. Arcaini L., Burcheri S., Rossi A., et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 2007, 18:346-350.
10. Ferreri A.J., Viale E., Guidoboni M., et al. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol 2006, 17:769-772.
11. Ferreri A.J., Guidoboni M., Ponzoni M., et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004, 96:586-594.
12. Chanudet E., Zhou Y., Bacon C.M., et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol 2006, 209:344-351.
13. Stefanovic A., Lossos I.S. Extranodal marginal zone lymphoma of the ocular adnexa. Blood 2009, 114:501-510.
14. Rosado M., Byrne G., Ding F., et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2006, 107:467-472.
15. Zhang G.S., Winter J.N., Variakojis D., et al. Lack of an association between Chlamydia psittaci and ocular adnexal lymphoma. Leuk Lymphoma 2007, 48:577-583.
16. Cheuk W., Yuen H.K., Chan A.C., et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 2008, 32:1159-1167.
17. Jenkins C., Rose G., Bunce C., et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 2000, 84:907-913.
18. Mannami T., Yoshimo T., Oshima K., et al. Clinical histopathological and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001, 14:641-649.
19. Vega F., Lin P., Medeiros L. Extranodal lymphomas of the head and neck. Ann Diagn Pathol 2005, 9:340-350.
20. Streubel B., Simonitsch-Klupp I., Mullauer L., et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004, 18:1722-1726.
21. Chanudet E., Ye H., Ferry J., et al. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J Pathol 2009, 217:420-430.
22. Chanudet E., Ichimura K., Hamoudi R., et al. A20 is targeted by deletion and promotermethylation in MALT lymphoma. Leukemia 2010, 24:483-487.
23. McNally L., Jakobiec F., Knowles D. Clinical, morphologic, immunophenotypic, and molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasms in 17 patients. Am J Ophthalmol 1987, 103:555-568.
24. Coupland S., Foss H., Assaf C., et al. T-cell and T/natural killer cell lymphomas involving ocular and ocular adnexal tissues. Ophthalmology 1999, 106:2109-2120.
25. Sherman M., Van Dalen J., Conrad K. Bilateral orbital infiltration as the initial sign of a peripheral T-cell lymphoma presenting in a leukemic phase. Ann Ophthalmol 1990, 22:93-95.
26. Woog J.J., Kim Y.D., Yeatts R.P., et al. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology 2006, 113:140-147.
27. Ferry J., Fung C., Hasserjian R., et al. Ocular adnexal lymphomas: outcome in 181 patients. Mod Pathol 2008, 21(suppl 1):253A.
28. Fung C., Ferry J., Linggood R., et al. Extranodal marginal zone (MALT type) lymphoma of the ocular adnexa: a localized tumor with favorable outcome after radiation therapy. Proceedings of ASTRO Thirty-Seventh Annual Meeting. Int J Radiat Oncol Phys 1996, 36:199.
29. Bennett C., Putterman A., Bitran J., et al. Staging and therapy of orbital lymphomas. Cancer 1986, 57:1204-1208.
30. Smitt M., Donaldson S. Radiotherapy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Phys 1993, 26:59-66.
31. Platanias L., Putterman A., Vijayakumar S., et al. Treatment and prognosis of orbital non-Hodgkin's lymphomas. Am J Clin Oncol 1992, 15:79-83.
32. Eulau S., Hildebrand R., Warnke R., et al. Primary radiotherapy is curative for CS 1E orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 1997, 39:176.
33. Knowles D., Jakobiec F., McNally L., Burke J. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 1990, 21:959-973.
34. Medeiros L., Harmon D., Linggood R., Harris N. Immunohistologic features predict clinical behavior of orbital and conjunctival lymphoid infiltrates. Blood 1989, 74:2121-2129.
35. Knowles D., Jakobiec F. Ocular adnexal lymphoid neoplasms: clinical, histopathologic, electron microscopic, and immunologic characteristics. Hum Pathol 1982, 13:148-162.
36. Medeiros L., Harris N. Lymphoid infiltrates of the orbit and conjunctiva: a morphologic and immunophenotypic study of 99 cases. Am J Surg Pathol 1989, 13:459-471.
37. Assanasen T., Wannakrairot P., Keelawat S., et al. Extranodal malignant lymphoma of the upper aerodigestive tract in King Chulalongkorn Memorial Hospital according to WHO classification. J Med Assoc Thai 2004, 87(suppl 2):S249-S254.
38. Ezzat A.A., Ibrahim E.M., El Weshi A.N., et al. Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients. Head Neck 2001, 23:547-558.
39. Ree H.J., Ohsima K., Aozasa K., et al. Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil. Hum Pathol 2003, 34:610-616.
40. Kojima M., Nakamura N., Shimizu K., et al. Marginal zone B-cell lymphoma among primary B-cell lymphoma of Waldeyer's ring: histopathologic and immunohistochemical study of 16 tonsillectomy specimens. Int J Surg Pathol 2008, 16:164-170.
41. Krol A.D., Le Cessie S., Snijder S., et al. Waldeyer's ring lymphomas: a clinical study from the Comprehensive Cancer Center West population-based NHL registry. Leuk Lymphoma 2001, 42:1005-1013.
42. Tewfik T., Bond M., al-Ghamdi K., Bernard C. Burkitt's lymphoma of the tonsil in children. J Otolaryngol 1996, 25:205-238.
43. Laskar S., Bahl G., Muckaden M.A., et al. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required. Cancer 2007, 110:816-823.
44. Sakabe H., Bamba M., Nomura K., et al. MALT lymphoma at the base of the tongue developing without any background of immunodeficiency or autoimmune disease. Leuk Lymphoma 2003, 44:875-878.
45. Sobol S., Kost K.M. Nasopharyngeal Burkitt's lymphoma causing acute airway obstruction. Otolaryngol Head Neck Surg 2001, 124:334-335.
46. Li Y.X., Fang H., Liu Q.F., et al. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood 2008, 112:3057-3064.
47. Alizadeh A., Eisen M., Davis R., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
48. Rosenwald A., Wright G., Chan W., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma,. N Engl J Med 2002, 346:1937-1947.
49. Nakamura S., Jaffe E., Swerdlow S. EBV positive diffuse large B-cell lymphoma of the elderly. WHO classification tumours of haematopoietic and lymphoid tissues 2008, 243-244. IARC, Lyon. S. Swerdlow, E. Campo, N. Harris (Eds.).
50. Kapadia S.B., Roman L.N., Kingma D.W., et al. Hodgkin's disease of Waldeyer's ring: clinical and histoimmunophenotypic findings and association with Epstein-Barr virus in 16 cases. Am J Surg Pathol 1995, 19:1431-1439.
51. Treaba D.O., Eklund J.W., Wayne J., et al. Classical Hodgkin's lymphoma presenting with tongue involvement: a case report and review of the literature. Clin Lymphoma Myeloma 2006, 6:410-413.
52. Quinones-Avila Md P., Gonzalez-Longoria A.A., Admirand J.H., Medeiros L.J.: Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases. Am J Clin Pathol 2005, 123:651-656.
53. Louissaint A., Soupir C., Ganguly A., et al. Infectious mononucleosis: morphology and immunophenotype in cervical lymph nodes and Waldeyer's ring. Mod Pathol 2008, 21(suppl 1):263A.
54. Attygalle A.D., Liu H., Shirali S., et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light chain restriction. Blood 2004, 104:3343-3348.
55. Taddesse-Heath L., Pittaluga S., Sorbara L., et al. Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol 2003, 27:522-531.
56. Wenig B.M., Thompson L.D.R., Frankel S.S., et al. Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection: a clinicopathologic study of 12 cases. Am J Surg Pathol 1996, 20:572-587.
57. Harbo G., Grau C., Bundgaard T., et al. Cancer of the nasal cavity and paranasal sinuses: a clinico-pathological study of 277 patients. Acta Oncol 1997, 36:45-50.
58. Quraishi M., Bessell E., Clark D., et al. Non-Hodgkin's lymphoma of the sinonasal tract. Laryngoscope 2000, 110:1489-1492.
59. Cuadra-Garcia I., Proulx G., Wu C., et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol 1999, 23:1356-1369.
60. Laskin J.J., Savage K.J., Voss N., et al. Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis. Leuk Lymphoma 2005, 46:1721-1727.
61. Tomita Y., Ohsawa M., Mishiro Y., et al. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan,. Lab Invest 1995, 73:190-196.
62. Tomita Y., Ohsawa M., Qiu K., et al. Epstein-Barr virus in lymphoproliferative diseases in the sino-nasal region: close association with CD56+ immunophenotype and polymorphic-reticulosis morphology. Int J Cancer 1997, 70:9-13.
63. Kim G.E., Koom W.S., Yang W.I., et al. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Head Neck 2004, 26:584-593.
64. Chan J., Quintanilla-Martinez L., Ferry J., Peh S- C. Extranodal NK/T-cell lymphoma, nasal type. WHO classification tumours of haematopoietic and lymphoid tissues 2008, 285-288. IARC, Lyon. S. Swerdlow, E. Campo, N. Harris (Eds.).
65. Barrionuevo C., Zaharia M., Martinez M.T., et al. Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol 2007, 15:38-44.
66. Hsieh P.P., Tung C.L., Chan A.B., et al. EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma. Am J Clin Pathol 2007, 128:579-584.
67. Huang M.J., Jiang Y., Liu W.P., et al. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type, in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 2008, 70:166-174.
68. Kim S.J., Kim B.S., Choi C.W., et al. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type. Ann Oncol 2007, 18:1382-1387.
69. Wang B., Lu J.J., Ma X., et al. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity. Leuk Lymphoma 2007, 48:396-402.
70. Hoshida Y., Li T., Dong Z., et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer 2001, 91:869-875.
71. Momose A., Mizuno H., Kajihara S., et al. EBV-associated nasal-type NK/T-cell lymphoma of the nasal cavity/paranasal sinus in a renal allograft recipient. Nephrol Dial Transplant 2006, 21:1413-1416.
72. Kohler S., Iwatsuki K., Jaffe E., Chan J. Extranodal NK/T-cell lymphoma, nasal-type. Pathology and genetics: skin tumours 2006, 191-192. IARC, Lyon. P. LeBoit, G. Burg, D. Weedon, A. Sarasin (Eds.).
73. Kim Y., Chang S., Yang W.-I., et al. Primary NK/T cell lymphoma of the testis. Acta Haematol 2003, 109:95-100.
74. Kuo T.T., Shih L.Y., Tsang N.M. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol 2004, 12:375-387.
75. Chan J., Sin V., Wong K., et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997, 89:4501-4513.
76. Chan J.K.C., Tsang W.Y.W., Lau W.-H., et al. Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 1996, 77:1198-1205.
77. Hongyo T., Hoshida Y., Nakatsuka S., et al. p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan. Oncol Rep 2005, 13:265-271.
78. Ishii H., Ogino T., Berger C., et al. Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma. J Med Virol 2007, 79:562-572.
79. Lee J., Suh C., Park Y.H., et al. Extranodal natural killer T-cell lymphoma, nasal type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006, 24:612-618.
80. Xiang-Lan M., Zu-Lan S., Dan H., et al. Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma. Transl Res 2008, 151:303-308.
81. Oprea C., Cainap C., Azoulay R., et al. Primary diffuse large B-cell non-Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases. Br J Haematol 2005, 131:468-471.
82. Pomilla P., Morris A., Jaworek A. Sinonasal non-Hodgkin's lymphoma in patients infected with human immunodeficiency virus: report of three cases and review. Clin Infect Dis 1995, 21:137-149.
83. Shiong Y.S., Lian J.D., Lin C.Y. Epstein-Barr virus associated T-cell lymphoma of the maxillary sinus in a renal transplant recipient. Transplant Proc 1992, 24:1929-1931.
84. Tran L., Mark R., Fu Y., et al. Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity: a report of 18 cases with stage IE disease. Am J Clin Oncol (CCT) 1992, 15:222-225.
85. Abbondanzo S., Wenig B. Non-Hodgkin's lymphoma of the sinonasal tract: a clinicopathologic and immunophenotypic study of 120 cases. Cancer 1995, 75:1281-1291.
86. Frierson H., Innes D., Mills S., Wick M. Immunophenotypic analysis of sinonasal non-Hodgkin's lymphomas. Hum Pathol 1989, 20:636-642.
87. Hausdorff J., Davis E., Long G., et al. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Cancer J Sci Am 1997, 3:303-311.
88. Inaki S., Okamura H., Chikamori Y. Adult T-cell leukemia/lymphoma originating in the paranasal sinus. Arch Otolaryngol Head Neck 1988, 114:1471-1473.
89. Nakamura K., Uehara S., Omagari J., et al. Primary non-Hodgkin lymphoma of the sinonasal cavities: correlation of CT evaluation with clinical outcome. Radiology 1997, 204:431-435.
90. Chetty R., Hlatswayo N., Muc R., et al. Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology 2003, 42:605-609.
91. Schichman S., McClure R., Schaefer R., Mehta P. HIV and plasmablastic lymphoma manifesting in sinus, testicles and bones: a further expansion of the disease spectrum. Am J Hematol 2004, 77:291-295.
92. Kim J.E., Kim Y.A., Kim W.Y., et al. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk Lymphoma 2009, 50:582-587.
93. Weiss L., Gaffey M., Chen Y.-Y., Frierson H. Frequency of Epstein-Barr viral DNA in "western" sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am J Surg Pathol 1992, 16:156-162.
94. Duncavage J., Campbell B., Hanson G., et al. Diagnosis of malignant lymphomas of the nasal cavity, paranasal sinuses and nasopharynx. Laryngoscope 1983, 93:1276-1280.
95. Jacobs C., Hoppe R. Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 1985, 11:357-364.
96. Lewis W.B., Perlman P., Lasi J. Pediatric American Burkitt's lymphoma of the sphenoid sinus. Otolaryngol Head Neck Surg 2000, 123:642-644.
97. Ferry J., Harris N. Lymphoma and lymphoid hyperplasia in head and neck sites. Head and neck surgical pathology 2001, Lippincott, Williams & Wilkins, Philadelphia. B. Pilch (Ed.).
98. Wu L., Cheng J., Maruyama S., et al. Lymphoepithelial cyst of the parotid gland: its possible histopathogenesis based on clinicopathologic analysis of 64 cases. Hum Pathol 2009, 40:683-692.
99. Ihrler S., Zietz C., Riederer A., et al. HIV-related parotid lymphoepithelial cysts: immunohistochemistry and 3-D reconstruction of surgical and autopsy material with special reference to formal pathogenesis. Virchows Arch 1996, 429:139-147.
100. Harris N. Lymphoid proliferations of the salivary glands. Am J Clin Pathol 1999, 111:S94-S103.
101. Dave S.P., Pernas F.G., Roy S. The benign lymphoepithelial cyst and a classification system for lymphocytic parotid gland enlargement in the pediatric HIV population,. Laryngoscope 2007, 117:106-113.
102. Geyer J., Ferry J., Harris N.L., et al. Chronic sclerosing sialadenitis is an IgG4-associated disease. Am J Surg Pathol 2010, 34:202-210.
103. Kitagawa S., Zen Y., Harada K., et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner's tumor). Am J Surg Pathol 2005, 29:783-791.
104. Ochoa E.R., Harris N.L., Pilch B.Z. Marginal zone B-cell lymphoma of the salivary gland arising in chronic sclerosing sialadenitis (Küttner tumor). Am J Surg Pathol 2001, 25:1546-1550.
105. Hsi E.D., Siddiqui J., Schnitzer B., et al. Analysis of immunoglobulin heavy chain gene rearrangement in myoepithelial sialadenitis by polymerase chain reaction. Am J Clin Pathol 1996, 106:498-503.
106. Carbone A., Gloghini A., Ferlito A. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the MALT type. Ann Otol Rhinol Laryngol 2000, 109:1170-1175.
107. Barnes L., Myers E., Prokopakis E. Primary malignant lymphoma of the parotid gland. Arch Otolaryngol Head Neck Surg 1998, 124:573-577.
108. Jaehne M., Ussmuller J., Jakel K.T., Zschaber R. The clinical presentation of non-Hodgkin lymphomas of the major salivary glands,. Acta Otolaryngol 2001, 121:647-651.
109. Kojima M., Shimizu K., Nishikawa M., et al. Primary salivary gland lymphoma among Japanese: a clinicopathological study of 30 cases. Leuk Lymphoma 2007, 48:1793-1798.
110. Dunn P., Kuo T.T., Shih L.Y., et al. Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan. Acta Haematol 2004, 112:203-208.
111. Talal N., Sokoloff L., Bargh W. Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med 1967, 43:50-65.
112. Kassan S., Thomas T., Moutsopoulos H., et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1979, 89:888-892.
113. Ekstrom Smedby K., Vajdic C.M., Falster M., et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008, 111:4029-4038.
114. Engels E.A., Cerhan J.R., Linet M.S., et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol 2005, 162:1153-1161.
115. Royer B., Cazals-Hatem D., Sibilia J., et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997, 90:766-775.
116. Voulgarelis M., Skopouli F.N. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjögren's syndrome patients. Clin Rev Allergy Immunol 2007, 32:265-274.
117. Carrozzo M. Oral diseases associated with hepatitis C virus infection. Part 1. Sialadenitis and salivary gland lymphoma. Oral Dis 2008, 14:123-130.
118. Ramos-Casals M., la Civita L., de Vita S., et al. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection. Arthritis Rheum 2007, 57:161-170.
119. Papaxoinis G., Fountzilas G., Rontogianni D., et al. Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol 2008, 19:780-786.
120. Zucca E., Conconi A., Pedrinis E., et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003, 101:2489-2495.
121. Nakamura S., Ichimura K., Sato Y., et al. Follicular lymphoma frequently originates in the salivary gland. Pathol Int 2006, 56:576-583.
122. Lai R., Arber D.A., Chang K.L., et al. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 1998, 11:864-869.
123. Remstein E.D., Dogan A., Einerson R.R., et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America,. Am J Surg Pathol 2006, 30:1546-1553.
124. Streubel B., Lamprecht A., Dierlamm J., et al. t(14;18)(q32;q21) involving IgH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003, 101:2335-2339.
125. Kojima M., Nakamura S., Ichimura K., et al. Follicular lymphoma of the salivary gland: a clinicopathological and molecular study of six cases. Int J Surg Pathol 2001, 9:287-293.
126. Park C.K., Manning J.T., Battifora H., Medeiros L.J. Follicle center lymphoma and Warthin tumor involving the same anatomic site: report of two cases and review of the literature. Am J Clin Pathol 2000, 113:113-119.
127. Hew W., Carey F., Kernohan N., et al. Primary T cell lymphoma of salivary gland: a report of a case and review of the literature. J Clin Pathol 2002, 55:61-63.
128. Rahemtullah A., Longtine J.A., Harris N.L., et al. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol 2008, 32:1593-1607.
129. Takahashi H., Fujita S., Okabe H., et al. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity. Pathol Res Pract 1993, 189:300-311.
130. Stein H., Harris N., Campo E. Plasmablastic lymphoma. WHO classification tumours of haematopoietic and lymphoid tissues 2008, IARC, Lyon. S. Swerdlow, E. Campo, N. Harris (Eds.).
131. Delecluse H., Anagnostopoulos I., Dallenbach F., et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997, 89:1413-1420.
132. Kemp S., Gallagher G., Kabani S., et al. Oral non-Hodgkin's lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 105:194-201.
133. Solomides C.C., Miller A.S., Christman R.A., et al. Lymphomas of the oral cavity: histology, immunologic type, and incidence of Epstein-Barr virus infection. Hum Pathol 2002, 33:153-157.
134. van der Waal R.I., Huijgens P.C., van der Valk P., van der Waal I. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg 2005, 34:391-395.
135. Takahashi H., Kawazoe K., Fujita S., et al. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity. Pathol Res Pract 1996, 192:44-53.
136. Gulley M., Sargeant K., Grider D., et al. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 80:425-431.
137. Leong I., Fernandes B., Mock D. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 92:184-193.
138. Gaidano G., Cerri M., Capello D., et al. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol 2002, 119:622-628.
139. Lozada-Nur F., de Sanz S., Silverman S., et al. Intraoral non-Hodgkin's lymphoma in seven patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 82:173-178.
140. Shindoh M., Takami T., Arisue M., et al. Comparison between submucosal (extra-nodal) and nodal non-Hodgkin's lymphoma (NHL) in the oral and maxillofacial region. J Oral Pathol Med 1997, 26:283-289.
141. Rosenburg A., Biesma D., Sie-Go D., Slootweg P. Primary extranodal CD30-positive T-cell non-Hodgkin's lymphoma of the oral mucosa: report of two cases. Int J Oral Maxillofac Surg 1996, 25:57-59.
142. Folk G.S., Abbondanzo S.L., Childers E.L., Foss R.D. Plasmablastic lymphoma: a clinicopathologic correlation. Ann Diagn Pathol 2006, 10:8-12.
143. Scheper M.A., Nikitakis N.G., Fernandes R., et al. Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 100:198-206.
144. Shiboski C., Greenspan D., Dodd C., Daniels T. Oral T-cell lymphoma associated with celiac sprue: a case report. Oral Surg Oral Med Oral Pathol 1993, 76:54-58.
145. Dong H.Y., Scadden D.T., de Leval L., et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005, 29:1633-1641.
146. Castillo J., Pantanowitz L., Dezube B.J. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 2008, 83:804-809.
147. Vega F., Chang C.C., Medeiros L.J., et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005, 18:806-815.
148. Dawson M.A., Schwarer A.P., McLean C., et al. AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation: treatment with autologous stem-cell transplantation in a patient with severe haemophilia A. Haematologica 2007, 92:e11-e12.
149. Kojima M., Sugihara S., Iijima M., et al. Marginal zone B-cell lymphoma of minor salivary gland representing tumor-forming amyloidosis of the oral cavity: a case report. J Oral Pathol Med 2006, 35:314-316.
150. Albuquerque M., Migliari D., Sugaya N., et al. Adult T-cell leukemia/lymphoma with predominant bone involvement initially diagnosed by its oral manifestation: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000, 100:315-320.
151. Quarterman M., Lesher J., Davis L., et al. Rapidly progressive CD8-positive cutaneous T-cell lymphoma with tongue involvement. Am J Dermatol 1995, 17:287-291.
152. Sirois D., Miller A., Harwick R., Vonderheid E. Oral manifestations of cutaneous T-cell lymphoma: a report of eight cases. Oral Surg Oral Med Oral Pathol 1993, 75:700-705.
153. May S.A., Jones D., Medeiros L.J., et al. Oral-cutaneous CD4-positive T-cell lymphoma: a study of two patients. Am J Dermatopathol 2007, 29:62-67.
154. Whitt J.C., Dunlap C.L., Martin K.F. Oral Hodgkin lymphoma: a wolf in wolf's clothing, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104::e45-e51.
155. Colomo L., Loong F., Rives S., et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004, 28:736-747.
156. Agarwal M., Shenjere P., Blewitt R.W., et al. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa-an indolent lesion: report of 4 cases. Int J Surg Pathol 2008, 16:286-290.
157. Hirshberg A., Amariglio N., Akrish S., et al. Traumatic ulcerative granuloma with stromal eosinophilia: a reactive lesion of the oral mucosa. Am J Clin Pathol 2006, 126:522-529.
158. Laurent C., Do C., Gascoyne R.D., et al. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. J Clin Oncol 2009, 27:4211-4216.
159. Delsol G., Campo E., Gascoyne R.D. ALK positive DLBCL. WHO classification tumours of haematopoietic and lymphoid tissues 2008, IARC, Lyon. S. Swerdlow, E. Campo, N. Harris (Eds.).
160. Carbone A., Gloghini A., Vaccher E., et al. KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects: report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype. J Clin Pathol 2005, 58:1039-1045.
161. Chadburn A., Hyjek E., Mathew S., et al. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 2004, 28:1401-1416.
162. Carbone A., Gloghini A., Vaccher E., et al. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn 2005, 7:17-27.
163. Thieblemont C., Mayer A., Dumontet C., et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002, 87:105-111.
164. Cho J.H., Park Y.H., Kim W.S., et al. High incidence of mucosa-associated lymphoid tissue in primary thyroid lymphoma: a clinicopathologic study of 18 cases in the Korean population. Leuk Lymphoma 2006, 47:2128-2131.
165. Harrington K.J., Michalaki V.J., Vini L., et al. Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience. Br J Radiol 2005, 78:405-410.
166. Laing R.W., Hoskin P., Hudson B.V., et al. The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital,. Clin Oncol (R Coll Radiol) 1994, 6:300-304.
167. Derringer G., Thompson L., Frommelt R., et al. Malignant lymphoma of the thyroid gland. Am J Surg Pathol 2000, 24:623-639.
168. Pederson R., Pederson N. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology 1996, 28:25-32.
169. Skacel M., Ross C., Hsi E. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma,. Histopathology 2000, 37:10-18.
170. Niitsu N., Okamoto M., Nakamura N., et al. Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma. Ann Oncol 2007, 18:1203-1208.
171. Holm L., Blomgren H., Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985, 312:601-604.
172. Doi Y., Goto A., Murakami T., et al. Primary thyroid lymphoma associated with Graves' disease. Thyroid 2004, 14:772-776.
173. Isaacson P., Androulakis-Papachristou A. Follicular colonization in thyroid lymphoma. Am J Pathol 1992, 141:43-52.
174. Saxena A., Alport E.C., Moshynska O., et al. Clonal B cell populations in a minority of patients with Hashimoto's thyroiditis. J Clin Pathol 2004, 57:1258-1263.
175. Streubel B., Vinatzer U., Lamprecht A., et al. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2000, 19:652-658.
176. Mack L.A., Pasieka J.L. An evidence-based approach to the treatment of thyroid lymphoma. World J Surg 2007, 31:978-986.
177. Bacon C.M., Diss T.C., Ye H., et al. Follicular lymphoma of the thyroid gland. Am J Surg Pathol 2009, 33:22-34.
178. Koida S., Tsukasaki K., Tsuchiya T., et al. Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. Haematologica 2007, 92:e37-e40.
179. Chen H.I., Akpolat I., Mody D.R., et al. Restricted kappa/lambda light chain ratio by flow cytometry in germinal center B cells in Hashimoto thyroiditis. Am J Clin Pathol 2006, 125:42-48.
180. Wang S.A., Rahemtullah A., Faquin W.C., et al. Hodgkin's lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol 2005, 18:1577-1584.
181. Ansell S., Habermann T., Hoyer J., et al. Primary laryngeal lymphoma. Laryngoscope 1997, 107:1502-1506.
182. Diebold J., Audouin J., Viry B., et al. Primary lymphoplasmacytic lymphoma of the larynx: a rare localization of MALT- type lymphoma. Ann Otol Rhinol Laryngol 1990, 99:577-580. review.
183. Smith M., Browne J., Teot L. A case of primary laryngeal T-cell lymphoma
184. Kato S., Sakura M., Takooda S., et al. Primary non-Hodgkin's lymphoma of the larynx. J Laryngol Otol 1997, 111:571-574.
185. Kawaida M., Fukuda H., Shiotani A., et al. Isolated non-Hodgkin's malignant lymphoma of the larynx presenting as a large pedunculated tumor. ORL 1996, 58:171-174.
186. Korst R.J. Primary lymphoma of the subglottic airway in a patient with Sjögren's syndrome mimicking high laryngotracheal stenosis. Ann Thorac Surg 2007, 84:1756-1758.
187. Patiar S., Ramsden J.D., Freeland A.P. B-cell lymphoma of the larynx in a patient with rheumatoid arthritis. J Laryngol Otol 2005, 119:646-648.
188. Kania R.E., Hartl D.M., Badoual C., et al. Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the larynx. Head Neck 2005, 27:258-262.
189. Palenzuela G., Bernard F., Gardiner Q., Mondain M. Malignant B cell non-Hodgkin's lymphoma of the larynx in children with Wiskott Aldrich syndrome. Int J Pediatr Otorhinolaryngol 2003, 67:989-993.
190. Morgan K., MacLennan K., Narula A., et al. Non-Hodgkin's lymphoma of the larynx (stage 1E). Cancer 1989, 64:1123-1127.
191. Mok J., Pak M., Chan K., et al. Unusual T-and T/NK-cell non-Hodgkin's lymphoma of the larynx: a diagnostic challenge for clinicians and pathologists. Head Neck 2001, 23:625-628.
192. Nakamura S., Suchi T., Koshikawa T., et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than upper and lower respiratory tract. Am J Surg Pathol 1995, 19:284-296.
193. Isaacson P., Norton A. Extranodal lymphomas 1994, Churchill Livingstone, Edinburgh.
194. Cavalot A., Preti G., Vione N., et al. Isolated primary non-Hodgkin's malignant lymphoma of the larynx. J Laryngol Otol 2001, 115:324-326.
195. Horny H.-P., Kaiserling E. Involvement of the larynx by hemopoietic neoplasms: an investigation of autopsy cases and review of the literature. Pathol Res Pract 1995, 191:130-138.